Filter
2009
Filtered Results: 2009
Text search:
Dowse,
R.
Featured
Recommendations
245
New Publications
426
Language
Document type
No document type
1058
Guidelines
389
Studies & Reports
308
Manuals
106
Training Material
48
Strategic & Response Plan
40
Fact sheets
40
Situation Updates
10
Infographics
6
Brochures
2
Resource Platforms
2
Countries / Regions
India
125
Global
84
South Africa
50
Kenya
39
Latin America and the Carribbean
37
Brazil
37
Africa
33
Nepal
32
Senegal
30
Western and Central Europe
26
Tanzania
23
Congo, Democratic Republic of
23
Philippines
22
Ethiopia
21
Uganda
20
Zambia
20
Malawi
19
Nigeria
18
Bangladesh
17
Rwanda
15
Zimbabwe
15
Mozambique
15
Sierra Leone
14
Indonesia
14
Ghana
13
Burkina Faso
13
Germany
12
West and Central Africa
12
Liberia
12
Eastern Europe
11
Ukraine
10
Asia
10
South–East Asia Region
10
Haiti
9
Benin
8
Cameroon
8
Cambodia
8
Myanmar / Burma
8
Madagascar
8
Syria
7
Namibia
7
Tajikistan
6
Thailand
6
Afghanistan
6
Argentina
6
Russia
6
Pakistan
6
USA
5
East and Southern Africa
5
Angola
5
Lesotho
4
Middle East and North Africa
4
France
4
Vietnam
4
Sudan
4
Botswana
4
South Sudan
4
Eswatini/ Swaziland
4
Albania
3
Guinea
3
Guinea-Bissau
3
Venezuela
3
Eastern Europe and Central Asia
3
North America
3
Lebanon
3
Sri Lanka
3
Chad
3
Iraq
3
Somalia
3
Kazakhstan
2
Chile
2
Iran
2
Peru
2
Morocco
2
Qatar
2
Jordan
2
Saudi Arabia
2
Paraguay
2
United Kingdom
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Georgia
2
Central African Republic
2
Mali
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Turkey
1
Gambia
1
Togo
1
Canada
1
Laos
1
Estonia
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Malaysia
1
Jamaica
1
Denmark
1
Tunisia
1
Spain
1
Latvia
1
Southern Africa
1
Papua New Guinea
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Libya
1
Bhutan
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
643
Clinical Guidelines
362
Women & Child Health
149
Public Health
122
Key Resources
42
Capacity Building
33
Pharmacy & Technologies
13
Toolboxes
COVID-19
187
TB
175
HIV
166
Mental Health
136
NTDs
80
AMR
79
NCDs
77
Pharmacy
63
Caregiver
59
Rapid Response
50
Ebola
36
Planetary Health
34
Conflict
26
Refugee
25
Specific Hazards
21
Cholera
19
Polio
17
Global Health Education
13
Disability
8
Zika
7
Natural Hazards
4
Social Ethics
4
Health Financing Toolbox
3
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
The COVID-19 pandemic has led to large increases in healthcare waste, straining under resourced healthcare facilities and exacerbating environmental impacts from solid waste. This report quantifies the additional COVID-19 healthcare waste generated, describes current healthcare waste management syst...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Frequently asked questions on COVID-19 vaccination. Version 6, 12 February 2022
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Since the description of the first case of COVID-19 in Wuhan, Hubei province in China, in December 2019, much knowledge has been accumulated about the dynamics of evolution of the SARS-CoV-2 virus, contagion, disease progression, prevention and treatment.
interim guidance, 19 July 2021 (arabic version)
24 May 2021; Guidance for vaccinators on how to store, prepare, draw up and administer COVID-19 vaccines Updated May 2021 · Western Cape Edition
Practical Approach to Care Kit: Vaccine
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidance for the CO...
